Sibutramine
- Generic Name
- Sibutramine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H26ClN
- CAS Number
- 106650-56-0
- Unique Ingredient Identifier
- WV5EC51866
- Background
Sibutramine (trade name Meridia in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of obesity. It is a centrally acting stimulant chemically related to amphetamines thus it is classified as a Schedule IV controlled substance in the United States. In October ...
- Indication
For the treatment of obesity.
- Associated Conditions
- Obesity
- Associated Therapies
- -
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2002-05-21
- Last Posted Date
- 2014-05-21
- Lead Sponsor
- University of Tennessee
- Target Recruit Count
- 436
- Registration Number
- NCT00037752
- Locations
- 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath